Evaluation of a polymorphism in MYBPC3 in patients with anthracycline induced cardiotoxicity

Cardiotoxicity is the most serious side effect of anthracyclines (doxorubicin, daunorubicin or epirubicin). The incidence of anthracycline induced late cardiac toxicity (AIC) that is overt clinically is 3–5% in the Indian population. Polymorphism in intron 32 (deletion of 25 bp) of MYBPC3 has been s...

Descripción completa

Detalles Bibliográficos
Autores principales: Vinodhini, M. Thirumalai, Sneha, S., Nagare, R.P., Bindhya, S., Shetty, V., Manikandan, D., Ganesan, P., Sagar, T.G., Ganesan, T.S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Research Brief
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5993918/
https://www.ncbi.nlm.nih.gov/pubmed/29716714
http://dx.doi.org/10.1016/j.ihj.2017.07.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5993918/
https://www.ncbi.nlm.nih.gov/pubmed/29716714
http://dx.doi.org/10.1016/j.ihj.2017.07.001

Ejemplares similares